Control of B cell development by Ras-mediated activation of Raf

被引:131
作者
Iritani, BM
Forbush, KA
Farrar, MA
Perlmutter, RM [1 ]
机构
[1] Univ Washington, Dept Immunol, Seattle, WA 98195 USA
[2] Univ Washington, Dept Biochem Med Med Genet, Seattle, WA 98195 USA
[3] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA
[4] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA
[5] Merck & Co Inc, Merck Sharp & Dohme Res Labs, Rahway, NJ 07065 USA
关键词
B cell development; Raf; Ras; transgenic mice;
D O I
10.1093/emboj/16.23.7019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cell fate commitment in a variety of lineages requires signals conveyed via p21(ras). To examine the role of p21(ras) in the development of B lymphocytes, we generated transgenic mice expressing a dominant-negative form of Ras in B lymphocyte progenitors, using a novel transcriptional element consisting of the E mu enhancer and the lck proximal promoter. Expression of dominant-negative Ras arrests B cell development at a very early stage, prior to formation of the pre-B cell receptor. Furthermore, an activated form of Raf expressed in the same experimental system could both drive the maturation of normal pro-B cells and rescue development of progenitors expressing dominant-negative Ras. Hence p21(ras) normally regulates early development of B lymphocytes by a mechanism that involves activation of the serine/threonine kinase Raf.
引用
收藏
页码:7019 / 7031
页数:13
相关论文
共 106 条
  • [1] GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN (GAP) INTERACTS WITH THE P21-RAS EFFECTOR BINDING DOMAIN
    ADARI, H
    LOWY, DR
    WILLUMSEN, BM
    DER, CJ
    MCCORMICK, F
    [J]. SCIENCE, 1988, 240 (4851) : 518 - 520
  • [2] Positive and negative selection invoke distinct signaling pathways
    AlberolaIla, J
    Hogquist, KA
    Swan, KA
    Bevan, MJ
    Perlmutter, RM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (01) : 9 - 18
  • [3] SELECTIVE REQUIREMENT FOR MAP KINASE ACTIVATION IN THYMOCYTE DIFFERENTIATION
    ALBEROLAILA, J
    FORBUSH, KA
    SEGER, R
    KREBS, EG
    PERLMUTTER, RM
    [J]. NATURE, 1995, 373 (6515) : 620 - 623
  • [4] EXPRESSION OF THE C-MYC ONCOGENE UNDER CONTROL OF AN IMMUNOGLOBULIN ENHANCER IN E-MU-MYC TRANSGENIC MICE
    ALEXANDER, WS
    SCHRADER, JW
    ADAMS, JM
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (04) : 1436 - 1444
  • [5] FUNCTIONAL DISSECTION OF THE LCK PROXIMAL PROMOTER
    ALLEN, JM
    FORBUSH, KA
    PERLMUTTER, RM
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (06) : 2758 - 2768
  • [6] INVOLVEMENT OF P59FYN(T) IN INTERLEUKIN-5 RECEPTOR SIGNALING
    APPLEBY, MW
    KERNER, JD
    CHIEN, S
    MALISZEWSKI, CR
    BONDADAA, S
    PERLMUTTER, RM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (03) : 811 - 820
  • [7] E2A PROTEINS ARE REQUIRED FOR PROPER B-CELL DEVELOPMENT AND INITIATION OF IMMUNOGLOBULIN GENE REARRANGEMENTS
    BAIN, G
    MAANDAG, ECR
    IZON, DJ
    AMSEN, D
    KRUISBEEK, AM
    WEINTRAUB, BC
    KROP, I
    SCHLISSEL, MS
    FEENEY, AJ
    VANROON, M
    VANDERVALK, M
    TERIELE, HPJ
    BERNS, A
    MURRE, C
    [J]. CELL, 1994, 79 (05) : 885 - 892
  • [8] BAKER DA, 1994, LEUKEMIA, V8, P1970
  • [9] BALDARI CT, 1993, J BIOL CHEM, V268, P2693
  • [10] BRADFORD AP, 1995, MOL CELL BIOL, V15, P2849